Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Disease

• Publication date

  2014-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2014.04.016PMID 24801365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A de novo convergence of autism genetics and molecular neuroscience.

  2014cited by this paper
• Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a

  2014cited by this paper
• Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome.

  2014cited by this paper
• Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.

  2014cited by this paper
• Reducing GABAA α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome

  2013cited by this paper
• The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy

  2012cited by this paper
• Activity-Dependent Regulation of Inhibition via GAD67

  2012cited by this paper
• Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome.

  2012cited by this paper
• Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists

  2012cited by this paper
• Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model.

  2012cited by this paper
• Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

  2012cited by this paper
• Molecular and Cellular Alterations in Down Syndrome: Toward the Identification of Targets for Therapeutics

  2012cited by this paper
• Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome

  2012cited by this paper
• DYRK1A: a master regulatory protein controlling brain growth.

  2012cited by this paper
• The Fraction of Cortical GABAergic Neurons Is Constant from Near the Start of Cortical Neurogenesis to Adulthood

  2012cited by this paper
• Dysfunctional hippocampal inhibition in the Ts65Dn mouse model of Down syndrome.

  2012cited by this paper
• Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders

  2012cited by this paper
• Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn

  2011cited by this paper
• Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice

  2011cited by this paper
• Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.

  2011cited by this paper
• PSD-95 and PSD-93 Play Critical But Distinct Roles in Synaptic Scaling Up and Down

  2011cited by this paper
• Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly

  2011cited by this paper
• Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome

  2011cited by this paper
• Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.

  2011cited by this paper
• Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.

  2010cited by this paper
• Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome

  2010cited by this paper
• GABAB-GIRK2-mediated signaling in Down syndrome.

  2010cited by this paper
• Memantine Normalizes Several Phenotypic Features in the Ts65Dn Mouse Model of Down Syndrome

  2010cited by this paper
• Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A

  2010cited by this paper
• Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin

  2010cited by this paper
• Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down’s syndrome

  2010cited by this paper
• Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A

  2009cited by this paper
• Excitatory‐inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome

  2009cited by this paper
• The “Down Syndrome Critical Region” Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome

  2009cited by this paper
• Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test

  2008cited by this paper
• Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)

  2008cited by this paper
• Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.

  2008cited by this paper
• Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome

  2008cited by this paper
• Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK‐801

  2008cited by this paper
• Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

  2007cited by this paper
• Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities.

  2007cited by this paper
• Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.

  2007cited by this paper
• Mapping convulsants' binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites.

  2007cited by this paper
• Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region

  2007cited by this paper
• Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

  2007cited by this paper
• DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects.

  2006cited by this paper
• Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

  2004cited by this paper
• Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67‐GFP knock‐in mouse

  2003cited by this paper
• Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities.

  2003cited by this paper
• Model of autism: increased ratio of excitation/inhibition in key neural systems

  2003cited by this paper
• GABA and Schizophrenia: A Review of Basic Science and Clinical Studies

  2003cited by this paper
• Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice

  2002cited by this paper
• Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.

  2001cited by this paper
• Sex differences in sensitivity to seizures elicited by pentylenetetrazol in mice.

  2001cited by this paper
• SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice.

  2001cited by this paper
• The Down syndrome critical region.

  1999cited by this paper
• Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

  1997cited by this paper
• Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome

  1997cited by this paper
• A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.

  1995cited by this paper
• minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila.

  1995cited by this paper
• A mouse model for Down syndrome exhibits learning and behaviour deficits

  1995cited by this paper
• Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21

  1993cited by this paper
• Segmental trisomy as a mouse model for Down syndrome.

  1993cited by this paper
• Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome.

  1989cited by this paper

• Epigenetic treatment of synaptic and behavioral deficits in Dyrk1a-mutant mice.

  2026cites this paper
• Synaptic and intrinsic membrane defects disrupt early neural network dynamics in Down syndrome

  2025cites this paper
• DYRK1A in the physiology and pathology of the neuron-astrocyte axis

  2025cites this paper
• The Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders

  2025cites this paper
• Interneuron migration defects during corticogenesis contribute to Dyrk1a haploinsufficiency syndrome pathogenesis

  2025cites this paper
• Conditional learning increases inhibition of layer 4 excitatory neurons by somatostatin- and parvalbumin-expressing interneurons in the barrel cortex

  2025cites this paper
• Early postnatal GABAB antagonist treatment normalizes inhibitory/excitatory balance in neonatal Ts65Dn mice, a genetic model of down syndrome.

  2025cites this paper
• Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions

  2024cites this paper
• Dissecting the contribution of human chromosome 21 syntenic regions to recognition memory processes in adult and aged mouse models of Down syndrome

  2024cites this paper
• Enhanced fear memory after social defeat in mice is dependent on interleukin-1 receptor signaling in glutamatergic neurons

  2024cites this paper
• EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.

  2024cites this paper
• An inhibitory circuit-based enhancer of Dyrk1a function reverses Dyrk1a-associated impairment in social recognition

  2023cites this paper
• Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A

  2023cites this paper
• Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A

  2023cites this paper
• Altered motor learning and coordination in mouse models of autism spectrum disorder

  2023cites this paper
• Elucidating multifinal and equifinal pathways to developmental disorders by constructing real-world neurorobotic models

  2023cites this paper
• Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders

  2023cites this paper
• Investigating brain alterations in the Dp1Tyb mouse model of Down syndrome

  2023cites this paper
• Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21.

  2023influential citation
• Ts65Dn synaptic proteome partially recapitulates AD biochemical signature

  2023influential citation
• A synaptic molecular dependency network in knockdown of autism- and schizophrenia-associated genes revealed by multiplexed imaging.

  2023cites this paper
• Single-Nucleus Profiling Identifies Accelerated Oligodendrocyte Precursor Cell Senescence in a Mouse Model of Down Syndrome

  2023cites this paper
• Increased plasma DYRK1A with aging may protect against neurodegenerative diseases

  2023influential citation
• Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures

  2022cites this paper
• Impaired macroglial development and axonal conductivity contributes to the neuropathology of DYRK1A-related intellectual disability syndrome

  2022cites this paper
• Brain circuit pathology in Down syndrome: from neurons to neural networks

  2022cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3 b

  2022cites this paper
• DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes

  2022influential citation
• Perturbations of a causal synaptic molecular network in autism and schizophrenia revealed with multiplexed imaging

  2022cites this paper
• Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes

  2022influential citation
• Delving into the Genetic Causes of Language Impairment in a Case of Partial Deletion of NRXN1

  2022cites this paper
• Oxidative Stress-Induced Damage to the Developing Hippocampus Is Mediated by GSK3β

  2022cites this paper
• Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.

  2022cites this paper
• Effects of aneuploidy on cell behaviour and function

  2022cites this paper
• Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.

  2021cites this paper
• Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome

  2021cites this paper
• DYRK1A Overexpression in Mice Downregulates the Gonadotropic Axis and Disturbs Early Stages of Spermatogenesis

  2021cites this paper
• Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome

  2021cites this paper
• Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models

  2021cites this paper
• Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A

  2020cites this paper
• Polyphenols in the management of brain disorders: Modulation of the microbiota-gut-brain axis.

  2020cites this paper
• Modeling Down syndrome in animals from the early stage to the 4.0 models and next.

  2020cites this paper
• Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome.

  2020cites this paper
• Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome.

  2020cites this paper
• Neuroanatomy and behavior in mice with a haploinsufficiency of AT-rich interactive domain 1B (ARID1B) throughout development

  2020cites this paper
• De novo damaging variants associated with congenital heart diseases contribute to the connectome

  2020cites this paper
• Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice

  2020cites this paper
• Multi-influential interactions alters behaviour and cognition through six main biological cascades in Down syndrome mouse models

  2020cites this paper
• Altered Hippocampal-Prefrontal Neural Dynamics in models of Down Syndrome

  2019cites this paper
• Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila

  2019cites this paper
• DYRK1A Up-Regulation Specifically Impairs a Presynaptic Form of Long-Term Potentiation

  2019influential citation
• synaptic 3 plasticity in Drosophila 4 5 6 7

  2019cites this paper
• Cognitive function in mice with segmental trisomy of human chromosome 21 Down Syndrome genes

  2019influential citation
• Molecular mechanisms involved in the cerebral cortex development and their implications in neurodevelopmental disorders

  2019cites this paper
• Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models

  2019cites this paper
• Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome

  2019cites this paper
• Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.

  2019cites this paper
• Mechanisms underlying the EEG biomarker in Dup15q syndrome

  2019cites this paper
• Down syndrome: Neurobiological alterations and therapeutic targets

  2019cites this paper
• Down syndrome.

  2019cites this paper
• DYRK1A and cognition: A lifelong relationship

  2019cites this paper
• Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome

  2019cites this paper
• Traumatic Stress Produces Distinct Activations of GABAergic and Glutamatergic Neurons in Amygdala

  2018cites this paper
• receptors partially improves cognitive , electrophysiological and morphological hippocampal defects in the Ts 65 Dn model of Down syndrome

  2018cites this paper
• LPS-Induced Inflammation Abolishes the Effect of DYRK1A on IkB Stability in the Brain of Mice

  2018cites this paper
• Toward the Language Oscillogenome

  2018influential citation
• DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures.

  2018cites this paper
• Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration

  2018cites this paper
• GABAergic over‐inhibition, a promising hypothesis for cognitive deficits in Down syndrome

  2018cites this paper
• Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.

  2018cites this paper
• Neuronal overexpression of DYRK1A/minibrain alters motor decline, neurodegeneration and synaptic plasticity in Drosophila

  2018cites this paper
• DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives

  2018cites this paper
• Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

  2018cites this paper
• Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome

  2018influential citation
• DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome

  2018cites this paper
• Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A

  2018cites this paper
• 22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy

  2017cites this paper
• Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease

  2017cites this paper
• Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

  2017cites this paper
• Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

  2017cites this paper
• Characterising impaired synaptic plasticity and network function in a mouse model of Alzheimer’s Disease in Down Syndrome

  2017influential citation
• Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits

  2017cites this paper
• Rodent models in Down syndrome research: impact and future opportunities

  2017cites this paper
• Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors

  2017cites this paper
• Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues

  2017cites this paper
• The language oscillogenome

  2017influential citation
• Impaired neurogenesis of the dentate gyrus is associated with pattern separation deficits: A computational study.

  2016cites this paper
• Changing paradigms in Down syndrome

  2016cites this paper
• Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models.

  2016cites this paper
• Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex

  2016cites this paper
• Prioritizing the development of mouse models for childhood brain disorders.

  2016influential citation
• Connecting Synaptic Activity with Plasticity-Related Gene Expression: From Molecular Mechanisms to Neurological Disorders

  2016cites this paper
• DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome

  2016cites this paper
• Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome.

  2016cites this paper
• Bridging the Gap between Genes and Language Deficits in Schizophrenia: An Oscillopathic Approach

  2016influential citation
• Detecting Psychiatric Profile in Genetic Syndromes: A Comparison of Down Syndrome and Williams Syndrome

  2016cites this paper
• Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society

  2016cites this paper
• Altered regulation of the Spry2/Dyrk1A/PP2A triad by homocysteine impairs neural progenitor cell proliferation.

  2016cites this paper
• Autism spectrum disorder and epilepsy: Disorders with a shared biology.

  2015cites this paper
• Annual research review: Rare genotypes and childhood psychopathology--uncovering diverse developmental mechanisms of ADHD risk.

  2015cites this paper